New NSAID: First COX-2 Inhibitor for Horses Approved by FDA

A new option in equine pain relief marks progress in the development of safer non-steroidal anti-inflammatory drugs (NSAIDs) for horses. Firocoxib (trade name Equioxx), manufactured by Merial, is the first equine NSAID specifically targeting the cyclooxygenase-2 (COX-2) enzyme to be approved by the FDA, and it is the first new equine NSAID option for systemic administration since 1990. The drug

To continue reading this article, become a member of

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from Learn More

Free Newsletters

Sign up for the latest in:

From our partners